Drug Shortage Report for APO-FELODIPINE

Last updated on 2024-10-11 History
Report ID 235345
Drug Identification Number 02452375
Brand name APO-FELODIPINE
Common or Proper name FELODIPINE
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) FELODIPINE
Strength(s) 5MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 100 BTL
ATC code C08CA
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-08-13
Estimated end date 2024-10-11
Actual end date 2024-10-10
Shortage status Resolved
Updated date 2024-10-11
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2024-10-11 French Compare
v7 2024-10-11 English Compare
v6 2024-10-04 French Compare
v5 2024-10-04 English Compare
v4 2024-08-29 French Compare
v3 2024-08-29 English Compare
v2 2024-08-15 French Compare
v1 2024-08-15 English Compare

Showing 1 to 8 of 8